Right now the fifth patient is being evaluated, for GRNOPC1 phase one trial using stem cells to treat patients with spinal cord injuries.
This is not the time to sell at $2.00. This company could be $25.00 overnight if one of the test patients shows movement. Or if big pharma takes a position $8.00 is possible.
I think a sustainable big jump will take place some time in late spring 2012, when some kind of deal is leaked out and confirmed later. I believe "Chip" is busy doing that job right now.
Good luck in this rigged casino,
No comments:
Post a Comment